Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
about
SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasionSP100 inhibits ETS1 activity in primary endothelial cellsRecombinant IFN-α2a-NGR exhibits higher inhibitory function on tumor neovessels formation compared with IFN-α2a in vivo and in vitroPDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerA novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNAThe transcription factor Net regulates the angiogenic switchThe detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities.Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy.Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.IFNα-mediated remodeling of endothelial cells in the bone marrow niche.Serum immunoglobulin fused interferon-alpha inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells.Type I interferons inhibit the generation of tumor-associated macrophages.HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.Interferons and their stimulated genes in the tumor microenvironmentAntiproliferative Properties of Type I and Type II Interferon.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.VEGF secretion is inhibited by interferon-alpha in several melanoma cell lines.Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10.Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma.Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinomaGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.Angiogenesis and hematological malignancies.Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis.Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative DamageEnhancing the anti-angiogenic action of histone deacetylase inhibitors.Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation.Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression.The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature.Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice.Signal transducer and activator of transcription 1 (STAT1) is essential for chromium silencing of gene induction in human airway epithelial cells.Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma.Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.
P2860
Q24299104-FD036778-014B-45FA-88FC-28A7468E9098Q24321596-DC21FFF9-54BA-4C33-9C76-C7E0A139432FQ27316848-F4F59176-14D2-46B9-BC6A-80CF981EEE3AQ28085644-30FCDB72-19CE-4DE8-BF18-33F7A1280B1FQ28472818-FB1FC909-1AA4-4E43-8257-58CF1DAD0C31Q28504967-8BA794CB-FE3F-44D4-8131-4B9A32C9375DQ30497355-9C26407E-3DCF-47A4-A231-814CBA26ED0DQ33274608-4C058109-0BCC-4090-A00A-E4E55AED70A1Q33367487-C9C7F343-1360-4A70-A3BB-A6923FC5EEB5Q33383270-C1102DE7-9407-4DC3-925D-DD2DED0E955FQ33509884-FB38E5B5-526E-4C72-A637-9BF7F0DE7759Q33573798-2DE3874E-7A38-43D8-8D5B-BB50C80A291DQ33729945-68F7F342-AF48-4440-80C5-5EA084843AF3Q33943369-41BC559C-B003-4898-8D29-C8DA62256BC3Q33976964-C7B17C65-5C9A-452D-9244-E054FB6655A6Q33988567-AC685CB0-91CF-4ADB-93EB-33CC8DA31AA9Q34007700-759C60C0-A41E-4EBF-8DA8-B08926F34837Q34273836-DA260A89-8243-4292-AD56-BA2FCEE2B399Q34334206-7D0B7E18-CB9A-4992-B582-4D61D0E5085EQ34372146-7E08BDAF-D8DE-436A-A416-F7581431A3A6Q34425709-119D6C9C-C178-4CDF-8AB8-135F7FCC0F8CQ34634386-1EA858CE-4201-4DFC-BEC2-B8328EE8C2D6Q34995738-3051D4CC-C950-4A40-B4A6-E7173CDBE393Q34995745-2877F5CC-C39D-46C5-B010-8E47EC44B4CCQ35760798-C364BF6F-7D25-4535-A319-C8388738DAA9Q35791274-2C537B96-6C9E-47B8-84E3-3426C7C2FA00Q35829509-E2827B3D-6955-4688-A9DC-4A21F0B90DB6Q36194525-B5698D6E-CEE9-4543-9E10-12DF38FEA7DAQ36257360-836338C6-E74E-40C1-A699-0185909F1457Q36315988-34508FB1-4FB1-4782-A6F4-F1E0385DD4F3Q36325361-933B4C2A-FB01-4739-90EA-465811B5DD8CQ36406952-5F0EBB6C-90DC-4083-A714-83C3A9F7DC1BQ36523547-DF1A32D9-EE88-42D6-8423-2E578608B25DQ36614297-7E16350B-B862-4B04-9526-2A112BEAA438Q36893107-13B6D52A-9822-4D6E-8F3C-3A6B9EEEA75BQ37076616-0C4AB1E2-3B69-4034-BE38-809F6A89DA7BQ37111373-A0B73475-7DDD-4961-A648-F7B132F348AEQ37227353-759A221F-BEAC-4B04-BEE0-612EEA3DAD52Q37299992-79AEC6CB-4DCD-4F20-8A12-025DB966397BQ37470058-FAB724AF-0A23-4F57-B493-3177F8CC0A82
P2860
Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@en
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@nl
type
label
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@en
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@nl
prefLabel
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@en
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@nl
P2093
P2860
P356
P1476
Effects of interferon alpha on ...... iption and tumor angiogenesis.
@en
P2093
Arne Scholz
Bertram Wiedenmann
Georgia Schäfer
Kjell Oberg
Michael Höcker
Michael Schirner
Stefan Rosewicz
Zofia von Marschall
P2860
P304
P356
10.1093/JNCI/95.6.437
P407
P577
2003-03-01T00:00:00Z